Arbutus Biopharma launches US$230 million modified Dutch auction tender offer at US$5 to US$5.75 a share

Reuters2026/08/24 11:34

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Arbutus launched a modified Dutch auction tender offer to repurchase up to USD 230 million of common shares for cancellation.
Offer price range set at USD 5 to USD 5.75 per share.
Tender opened today; scheduled to expire Sept. 29, 2026, at 5:00 p.m. New York time, unless extended or terminated.
Repurchase funded from cash on hand; not subject to financing or a minimum tender condition.
At full subscription, buyback equals 20.2% to 23.2% of shares outstanding as of Aug. 19, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arbutus Biopharma Corp. published the original content used to generate this news brief on August 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Arbutus Biopharma launches US$230 million modified Dutch auction tender offer at US$5 to US$5.75 a share

You may also like

Crypto prices